XML 15 R3.htm IDEA: XBRL DOCUMENT v3.25.3
Offsets
Nov. 13, 2025
USD ($)
shares
Offset: 1  
Offset Payment:  
Offset Claimed true
Rule 457(p) Offset true
Registrant or Filer Name Trevi Therapeutics, Inc.
Form or Filing Type S-3
File Number 333-273030
Initial Filing Date Jun. 29, 2023
Fee Offset Claimed $ 2,243.56
Security Type Associated with Fee Offset Claimed Unallocated (Universal) Shelf
Security Title Associated with Fee Offset Claimed Unallocated (Universal Shelf)
Unsold Securities Associated with Fee Offset Claimed | shares 0
Unsold Aggregate Offering Amount Associated with Fee Offset Claimed $ 20,359,070.00
Termination / Withdrawal Statement All offerings of the unsold securities associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated.
Offset: 2  
Offset Payment:  
Offset Claimed false
Rule 457(p) Offset true
Registrant or Filer Name Trevi Therapeutics, Inc.
Form or Filing Type S-3
File Number 333-273030
Filing Date Jun. 29, 2023
Fee Paid with Fee Offset Source $ 2,243.56
Offset Note Pursuant to Rule 457(p) under the Securities Act, the registration fee applicable to the $200,000,000 of securities of the registrant being registered hereby in the amount of $27,620.00 is offset by $2,243.56, which represents the registration fee previously paid with respect to $20,359,070 of unsold securities under the registrant's Registration Statement on Form S-3 (File No. 333-273030) that was filed with the Securities and Exchange Commission (the "SEC") on June 29, 2023, as amended by Amendment No. 1 thereto that was filed with the SEC on August 11, 2023, which was declared effective by the SEC on August 15, 2023, resulting in a net registration fee due of $25,376.44. All offerings of the unsold securities associated with the claimed fee offset pursuant to Rule 457(p) have been completed or terminated.